Vitalhub (TSE:VHI) Given a C$13.50 Price Target by Raymond James Analysts

Raymond James set a C$13.50 price objective on Vitalhub (TSE:VHI) in a research report report published on Thursday morning,BayStreet.CA reports. The firm currently has an outperform rating on the stock.

A number of other brokerages also recently commented on VHI. Scotiabank set a C$14.00 target price on shares of Vitalhub and gave the stock an “outperform” rating in a research note on Thursday, January 30th. Canaccord Genuity Group lifted their price target on shares of Vitalhub from C$12.00 to C$12.50 and gave the company a “buy” rating in a research report on Thursday, January 16th. Five analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, Vitalhub currently has an average rating of “Buy” and a consensus price target of C$11.92.

Vitalhub Price Performance

VHI opened at C$9.66 on Thursday. The firm has a market capitalization of C$522.53 million, a price-to-earnings ratio of 157.12, a price-to-earnings-growth ratio of 1.18 and a beta of 1.26. The company’s 50 day simple moving average is C$10.49 and its two-hundred day simple moving average is C$10.31. Vitalhub has a 1-year low of C$5.80 and a 1-year high of C$12.09.

Vitalhub Company Profile

Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.